Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8200)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 7, 2023 (publication date) through Apr 7, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Jiang NZ, Bai MZ, Huang CF, Ma ZL, Zhong RY, Fu WK, Gao L, Tian L, Mi NN, Ma HD, Lu YW, Zhang ZA, Zhao JY, Yu HY, Zhang BP, Zhang XZ, Ren YX, Zhang C, Zhang Y, Yue P, Lin YY, Meng WB. First report on establishment and characterization of the extrahepatic cholangiocarcinoma sarcoma cell line CBC2T-2. World J Gastroenterol 2023; 29(41): 5683-5698 [PMID: 38077157 DOI: 10.3748/wjg.v29.i41.5683] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Jiang NZ, Bai MZ, Huang CF, Ma ZL, Zhong RY, Fu WK, Gao L, Tian L, Mi NN, Ma HD, Lu YW, Zhang ZA, Zhao JY, Yu HY, Zhang BP, Zhang XZ, Ren YX, Zhang C, Zhang Y, Yue P, Lin YY, Meng WB. First report on establishment and characterization of the extrahepatic cholangiocarcinoma sarcoma cell line CBC2T-2. World J Gastroenterol 2023; 29(41): 5683-5698 [PMID: 38077157 DOI: 10.3748/wjg.v29.i41.5683] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i41/5683.htm |
| Number | Citing Articles |
| 1 |
Jiahui Xi, Mingzhen Bai, Ruyang Zhong, Chongfei Huang, Ruoshui An, Long Gao, Haidong Ma, Liang Tian, Jinyu Zhao, Ningzu Jiang, Xiang He, Leiqing Wang, Zihe Dong, Ping Yue, Yanyan Lin, Zhongtian Bai, Wenbo Meng. CBC3T-3: a novel patient-derived cisplatin-resistant distal cholangiocarcinoma cell line harboring multiple TP53 missense mutations. Human Cell 2026; 39(4) doi: 10.1007/s13577-026-01369-1
|